Continuing Medical Education
The University of Florida College of Medicine designates this live activity for a maximum of 13.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Describe the current state of knowledge and emerging trends in precision medicine in clinical practice.
- Apply genetic and pharmacogenetic data to solve complex patient cases.
- Use pharmacogenetic testing in a multidisciplinary primary care practice.
- Demonstrate the case for preemptive pharmacogenomic testing in a variety of clinical settings.
- Describe challenges and solutions for the application of precision medicine in diverse patient populations.
- Illustrate solutions to common precision medicine implementation barriers.
- Discuss emerging ethical, legal and social implications in precision medicine, including liability and health disparity.
- Physician Assistants
This activity is associated with a registration fee.
Financial support has not been provided for this activity.
Continuing Pharmacy Education
- This is an application-based activity.
- Participants are eligible to receive 13.75 contact hours available across two days.
- View the conference agenda for Day One and Day Two
|Activity Title||Contact Hours||UAN|
|Day 1: UF Precision Medicine Conference||6.75||0012-0000-18-071-L04-P|
|Day 2: UF Precision Medicine Conference||7.0||0012-0000-18-072-L04-P|
Partial credit will not be awarded to pharmacists. Participants will only receive CPE credit for the activities attended.
To receive credit, participants must sign into the conference each day, demonstrate full and satisfactory participation, and complete an online program evaluation.
Financial support was received by Illumina, Inc.
- The University of Florida College of Pharmacy will report CPE credit to CPE Monitor and CE Broker when applicable. If you would like a paper statement of credit, you may print it from your NABP e-profile.
- All pharmacists maintain their own license and/or certification and it is their responsibility to follow up with the Office of Continuing Education at the University of Florida if any CE credit discrepancies are found.
- It is at the University’s discretion to award or deny credit to a late claiming participant (i.e. after 60 days of the participant engaging in a CPE activity) as it is the University’s CE activity and the provider needs to ensure the requirements necessary for credit are successfully completed.
- The University may request access to CPE Monitor® if the activity in question occurred within the previous 6 months and with an appropriate reason for access, i.e. power outage, etc.
- The University of Florida College of Medicine designates this live activity for a maximum of 13.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University of Florida is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.